Lung Neoplasm Malignant

Oncology
2
Pipeline Programs
3
Companies
3
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
1
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

DS
Daiichi SankyoChina - Shanghai
1 program
1
MK-1084Phase 1/21 trial
Active Trials
NCT07286149Recruiting190Est. May 2037
Blueprint Medicines
Blueprint MedicinesMA - Cambridge
1 program
1
BLU-451Phase 11 trial
Active Trials
NCT05241873Terminated103Est. Jul 2024
Galvanize Therapeutics
Galvanize TherapeuticsCA - San Carlos
1 program
Aliya Pulsed Electric FieldsN/A1 trial
Active Trials
NCT05890872CompletedEst. Aug 2025

Trial Timeline

Clinical trial activity over time

2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
Daiichi SankyoMK-1084
Blueprint MedicinesBLU-451
Galvanize TherapeuticsAliya Pulsed Electric Fields

Clinical Trials (3)

Total enrollment: 293 patients across 3 trials

NCT07286149Daiichi SankyoMK-1084

A Clinical Study of MK-1084 With Other Treatments for Non-small Cell Lung Cancer (MK-3475-01F)

Start: Mar 2026Est. completion: May 2037190 patients
Phase 1/2Recruiting
NCT05241873Blueprint MedicinesBLU-451

(Concerto) Study of BLU-451 in Advanced Cancers With EGFR Exon 20 Insertion Mutations

Start: Mar 2022Est. completion: Jul 2024103 patients
Phase 1Terminated
NCT05890872Galvanize TherapeuticsAliya Pulsed Electric Fields

Aliya™ Pulsed Electric Fields (PEF) for Advanced Cancer

Start: Sep 2023Est. completion: Aug 2025
N/ACompleted

Related Jobs in Oncology

Senior Research Associate, Immuno-Oncology

SystImmune
2m ago
$60K - $85K/yr

Research Associate I/II, Immuno-Oncology

SystImmune
2m ago

Office Administrator

SystImmune
2m ago
$60K - $80K/yr

Scientist/Sr Scientist

TwoStep Therapeutics
San Carlos
13m ago

Working Student Office Management Support (m/f/d)

Mindpeak
Hamburg
16m ago

Senior Medical Project Manager (m/f/d)

Mindpeak
Hamburg
16m ago

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 actively recruiting trials targeting 293 patients
3 companies competing in this space

Related Indications

Breast Cancer(530)Non-small Cell Lung Cancer(373)Prostate Cancer(371)Multiple Myeloma(244)Advanced Solid Tumors(221)Acute Myeloid Leukemia(204)Cancer(187)Neoplasms(173)Colorectal Cancer(166)Advanced Solid Tumor(165)